Institute of Endocrinology and Diabetes

• Thyroid pathology
• Pituitary pathology
• Pancreatic pathology
• Adrenal pathology
• Oncological endocrinology
• Ablation methods in endocrinology

Thyroid Diseases

• tumors, cysts, toxic and nodular goiter, myxedema, thyroiditis, parathyroid tumors

Within the shortest timeframe — up to 48 hours — a complete endocrinological hormone profile is performed, utilizing isotope and computed tomography techniques along with biopsy methods that definitively confirm the histological diagnosis.

Pancreatic Diseases

Type I and II diabetes mellitus, juvenile diabetes, multiple endocrine neoplasia, glucagonomas, somatostatinomas, gastrinomas (Zollinger-Ellison syndrome), insulinomas, pancreatic tumors, hemochromatosis. Investigation and diagnosis confirmation are performed with genotype determination of diabetes, prognosis, and precise treatment strategy. Patients undergo outpatient or inpatient care (in cases of ketoacidosis or hyperosmolar coma) for blood sugar correction. Levels of insulin, somatomedin, glucagon, and glycosylated hemoglobin are determined.

Adrenal Diseases

Adrenal pathologies become the subject of discussion among endocrinologists, nephrologists, and urologists. The two most common problems are tumors (Cushing's syndrome) and adrenal insufficiency (Addison's disease). In the institute's daily practice, angiographic, isotope, and ultrasound examination methods for adrenal tumors allow diagnoses to be established with the highest degree of accuracy. When necessary, positron emission methods complete the path to a definitive diagnosis.

• Diagnosis and treatment of Type I and II diabetes mellitus.
• Diagnosis and treatment of diabetes target organ damage
• Insulin pump installation and treatment adjustment

Diabetes mellitus, like arterial hypertension, affects every second person on the planet over the age of 65. The disease is the most powerful generator of vascular atherosclerosis and is regarded as simultaneously three active risk factors for cerebrovascular and cardiovascular disease.
Childhood and adolescent diabetes pathology — Type I insulin-dependent diabetes.

The autoimmune problem of producing antibodies against pancreatic cells leads to zero insulin concentrations in patients' blood, and as a rule, the only possible and correct therapy for these patients is insulin therapy. The introduction of insulin pumps has opened a new era of quality of life for children and adolescents suffering from Type I diabetes, preventing numerous treatment and disease complications.
An incredible breakthrough in diabetes diagnosis and treatment has emerged for patients with Type II — insulin-resistant diabetes. These are typically patients over the age of 45 who are overweight, have low physical activity, i.e., have the so-called metabolic syndrome.

Such patients have sufficient or even elevated insulin levels in their blood.
Before deciding on the treatment strategy for such a patient, a study is mandatory to determine the pancreatic potential using the C-peptide test and the adequacy of insulin secretion in response to food intake (C-peptide stress test). Glucose Holter monitoring allows determination of blood glucose levels over 24 hours using a special sensor with a subcutaneous electrode that continuously measures glucose content throughout the day. Additionally, during the examination, levels of counter-regulatory hormones that affect blood glucose levels are determined.

Having established the diabetes status at the time of examination, the diabetologist mandatorily examines diabetes target organs. To determine or exclude: eye pathology — diabetic retinopathy, kidneys — renal failure and nephropathy, heart — ischemic heart disease, extremity damage — diabetic neuropathy, diabetic foot.
Each of the above pathologies has its effective solution, which prevents life-threatening complications and preserves the patient's quality of life for many years.